).
12. Mahasandana, C., et al., Lancet, 335, 61 (1990).
13. D’Angelo, A., et al., J. Clin. Invest., 81, 1445
(1988).
kmr 05/01
Sigma brand products are sold through Sigma-Aldrich, Inc.
Sigma-Aldrich
proliferation by
71%. However, cells treated with this level of
-tocopherol exhibited reduced viability (81% vs. 96%
for control cells).
This product has been shown to interact with cytosolic
Protein Kinase
).
14. Adams, M.E., et al., Neuron, 11, 531 (1993).
15. Peters, M.F., et al., J. Cell Biol., 138, 81 (1997).
ER/KAA 01/02
Sigma brand products are sold through Sigma-Aldrich, Inc.
Sigma-Aldrich
Makromol. Chem., 48, 160 (1961).
15. Journal of Research of the National Bureau of Standards, 50, 81 (1953).
16. Jermyn., M.A., Anal. Biochem., 68, 332 (1975).
17. Supplier's Data
18. Ingelman, B.
to Influenza Virus Following
Malaria Infection". University College London,
Ph.D. dissertation, p. 81 (2012).
12. Wang, Yan, "Développement de l’immunothérapie
anti-tumorale médiée par vecteur bactérien
, Makromol. Chem., 48, 160 (1961).
17. Journal of Research of the National Bureau of Standards, 50, 81 (1953).
18. Jermyn, M.A., Anal. Biochem., 68, 332 (1975).
19. Ingelman, B. and Halling, M.S., Ark.
, Makromol. Chem., 48, 160 (1961).
17. Journal of Research of the National Bureau of Standards, 50, 81 (1953).
18. Jermyn, M.A., Anal. Biochem., 68, 332 (1975).
19. Ingelman, B. and Halling, M.S., Ark.
, Makromol. Chem., 48, 160 (1961).
17. Journal of Research of the National Bureau of Standards, 50, 81 (1953).
18. Jermyn, M.A., Anal. Biochem., 68, 332 (1975).
19. Ingelman, B. and Halling, M.S., Ark.
, Makromol. Chem., 48, 160 (1961).
17. Journal of Research of the National Bureau of Standards, 50, 81 (1953).
18. Jermyn, M.A., Anal. Biochem., 68, 332 (1975).
19. Ingelman, B. and Halling, M.S., Ark.
glutathione, 0.1 mM EDTA, 0.25 mM DTT, 0.1 mM
PMSF, and 25% glycerol.
Molecular mass: CDK1 ∼58 kDa and CyclinA1 ∼81 kDa
Purity: 70–95% (SDS-PAGE, see Figure 1)
Specific Activity: 70-95 nmole/min/mg (
, Makromol. Chem., 48, 160 (1961).
17. Journal of Research of the National Bureau of Standards, 50, 81 (1953).
18. Jermyn, M.A., Anal. Biochem., 68, 332 (1975).
19. Ingelman, B. and Halling, M.S., Ark.
, Makromol. Chem., 48, 160 (1961).
17. Journal of Research of the National Bureau of Standards, 50, 81 (1953).
18. Jermyn, M.A., Anal. Biochem., 68, 332 (1975).
19. Ingelman, B. and Halling, M.S., Ark.
, Makromol. Chem., 48, 160 (1961).
17. Journal of Research of the National Bureau of Standards, 50, 81 (1953).
18. Jermyn, M.A., Anal. Biochem., 68, 332 (1975).
19. Ingelman, B. and Halling, M.S., Ark.
, Makromol. Chem., 48, 160 (1961).
17. Journal of Research of the National Bureau of Standards, 50, 81 (1953).
18. Jermyn, M.A., Anal. Biochem., 68, 332 (1975).
19. Ingelman, B. and Halling, M.S., Ark.
, Makromol. Chem., 48, 160 (1961).
17. Journal of Research of the National Bureau of Standards, 50, 81 (1953).
18. Jermyn, M.A., Anal. Biochem., 68, 332 (1975).
19. Ingelman, B. and Halling, M.S., Ark.
, Makromol. Chem., 48, 160 (1961).
17. Journal of Research of the National Bureau of Standards, 50, 81 (1953).
18. Jermyn, M.A., Anal. Biochem., 68, 332 (1975).
19. Ingelman, B. and Halling, M.S., Ark.
glutathione,
0.1 mM EDTA, 0.25 mM DTT, 0.1 mM PMSF, and 25%
glycerol.
Molecular mass: CDK1 ∼58 kDa and CyclinA1 ∼81 kDa
Purity: 70–95% (SDS-PAGE, see Figure 1)
Specific Activity: 32-48 nmole/min/mg (
, Makromol. Chem., 48, 160 (1961).
17. Journal of Research of the National Bureau of Standards, 50, 81 (1953).
18. Jermyn, M.A., Anal. Biochem., 68, 332 (1975).
19. Ingelman, B. and Halling, M.S., Ark.
, Makromol. Chem., 48, 160 (1961).
17. Journal of Research of the National Bureau of Standards, 50, 81 (1953).
18. Jermyn, M.A., Anal. Biochem., 68, 332 (1975).
19. Ingelman, B. and Halling, M.S., Ark.
evolution of pathogenicity in
Candida glabrata". Queen’s University Belfast,
Ph.D. dissertation, p. 81 (2020).
23. Lam, F.H. et al., Protocol Exchange,
doi:10.1038/nprot.2008.121 (2008).
24. Hong